glucosamine has been researched along with cyclosporine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Lemmen, C; Schumacher, U; Willershausen-Zönnchen, B | 1 |
| Berson, M; Callens, A; Lorette, G; Machet, L; Pourcelot, L; Vaillant, L | 1 |
| Johnson, RB; Odlum, O; Pylypas, SP; Zebrowski, EJ | 1 |
| Clausell, N; Rabinovitch, M | 1 |
| Inman, RD; Stone, M | 1 |
| Van Gossum, A | 1 |
| Calastrini, C; Calvitti, M; Carinci, F; Caruso, A; De Mattei, M; Locci, P; Luigi Bedani, P; Scapoli, L; Stabellini, G | 1 |
| Giannoukakis, N; Harnaha, J; Lakomy, R; Lu, L; Ma, L; Machen, J; Qian, S; Robbins, PD; Rudert, WA; Trucco, M; Wright, M | 1 |
| Ahn, BJ; Cheong, KA; Choi, Y; Jin, SY; Kwon, HB; Lee, AY; Lee, J | 1 |
| Cheong, KA; Choi, YS; Kim, CH; Lee, AY | 1 |
| Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D | 1 |
| Kim, CH; Kim, JY; Lee, AY | 1 |
1 review(s) available for glucosamine and cyclosporine
| Article | Year |
|---|---|
Recent developments in the therapy of spondyloarthropathies.
Topics: Alleles; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Reactive; Chronic Disease; Ciprofloxacin; Cyclosporine; Double-Blind Method; Drug Combinations; Follow-Up Studies; Forecasting; Glucosamine; Humans; Immunosuppressive Agents; Lymecycline; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Placebos; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Spondylarthropathies; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
1 trial(s) available for glucosamine and cyclosporine
| Article | Year |
|---|---|
Combination of glucosamine improved therapeutic effect of low-dose cyclosporin A in patients with atopic dermatitis: a pilot study.
Topics: Adolescent; Adult; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; Female; Glucosamine; Humans; Interferon-gamma; Interleukin-4; Leukocytes, Mononuclear; Linear Models; Male; Pilot Projects; Severity of Illness Index; Young Adult | 2013 |
14 other study(ies) available for glucosamine and cyclosporine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Influence of cyclosporine A on growth and extracellular matrix synthesis of human fibroblasts.
Topics: Cell Count; Cells, Cultured; Chromatography, Ion Exchange; Cyclosporine; DNA; Extracellular Matrix; Fibroblasts; Gingiva; Glucosamine; Humans; Thymidine; Time Factors | 1992 |
Ultrasound imaging of psoriatic skin: a noninvasive technique to evaluate treatment of psoriasis.
Topics: Adult; Aged; Cell Division; Cyclosporine; Drug Combinations; Epidermis; Female; Follow-Up Studies; Glucosamine; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Skin; Sulfasalazine; Ultrasonography | 1994 |
Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine.
Topics: Adult; Cell Count; Cells, Cultured; Chronic Disease; Cyclosporine; Extracellular Matrix; Fibroblasts; Gingiva; Gingival Hyperplasia; Glucosamine; Humans; Kidney Transplantation; Male; Nifedipine; Proteoglycans; Tritium | 1994 |
Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets.
Topics: Animals; Antibodies; Blotting, Northern; Cell Division; Cells, Cultured; Coronary Vessels; Cyclosporine; DNA; DNA Probes; Dose-Response Relationship, Drug; Fibronectins; Glucosamine; Glycosaminoglycans; Heart Transplantation; Humans; Immunoglobulin G; Interleukin-1; Kinetics; Methionine; Muscle, Smooth, Vascular; Recombinant Proteins; RNA, Messenger; Sulfur Radioisotopes; Swine; Transplantation, Homologous; Tritium | 1993 |
[Therapy of chronic inflammatory intestinal disease].
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Combinations; Gastrointestinal Agents; Glucosamine; Humans; Immunosuppressive Agents; Infliximab; Sulfasalazine | 2000 |
Cyclosporin A and transforming growth factor beta modify the pattern of extracellular glycosaminoglycans without causing cytoskeletal changes in human gingival fibroblasts.
Topics: Cells, Cultured; Cyclosporine; Cytoskeleton; Extracellular Space; Fibroblasts; Gingiva; Glucosamine; Glycosaminoglycans; Humans; Immunosuppressive Agents; Transforming Growth Factor beta | 2002 |
Immunosuppressive effects of glucosamine.
Topics: Adenosine Triphosphate; Animals; beta-Galactosidase; Cyclosporine; Dendritic Cells; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Glucosamine; Humans; Immunosuppressive Agents; Jurkat Cells; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; NFATC Transcription Factors; Nuclear Proteins; Tacrolimus; Time Factors; Transcription Factors; Transplantation Tolerance | 2002 |
Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Animals; Antigens, Dermatophagoides; CD4 Antigens; Cells, Cultured; Cyclosporine; Cytokines; Dermatitis, Atopic; Dermatophagoides farinae; Drug Dosage Calculations; Drug Therapy, Combination; Eosinophils; Filaggrin Proteins; Glucosamine; Humans; Immunoglobulin E; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Intermediate Filament Proteins; Keratins; Male; Mast Cells; Mice; Mice, Inbred Strains; Skin; T-Lymphocytes, Regulatory; Th1-Th2 Balance | 2013 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.
Topics: Aminoquinolines; Animals; Cyclosporine; Dermatitis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucosamine; Imiquimod; Immunomodulation; Mice; Mice, Inbred C57BL; Organ Size; Psoriasis; Spleen; T-Lymphocytes, Regulatory | 2015 |